Results 251 to 260 of about 9,130,139 (414)

Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research. [PDF]

Metabolites, 2023
Akyol S, Ashrafi N, Yilmaz A, Turkoglu O, Graham SF.   +4 more
europepmc   +1 more source

Long-term outcome of presymptomatic testing in Huntington disease [PDF]

, 2008
Marcela Gargiulo, Séverine Lejeune, Marie‐Laure Tanguy, Khadija Lahlou‐Laforêt, Anne Faudet, David Cohen, Josué Feingold, Alexandra Dürr   +7 more
openalex   +1 more source

Spasmodic Dysphonia

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Spasmodic dysphonia is a laryngeal dystonia that can present as adductor, abductor, or mixed types, with or without tremor. The etiology is not understood fully. Comprehensive evaluation is required to establish the diagnosis. Treatments include voice therapy, medications, botulinum toxin injection, laryngeal surgery, deep brain stimulation ...
Aaron J. Jaworek, Robert T. Sataloff
wiley   +1 more source

Vitamin C Transport Deficiency Alters Striatal Dopamine Gene Expression and Metabolism in YAC128 Huntington Disease Mice. [PDF]

Genes Brain Behav
Tienda AA, Harrison FE, Wilcox JM.
europepmc   +1 more source

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study [PDF]

, 2008
Christopher F. McNicoll, Jeanne C. Latourelle, Marcy E. MacDonald, Mark Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten, Ray L. Watts, Mark Guttman, Brad A. Racette, Joel S. Perlmutter, Anwar Ahmed, Holly A. Shill, Carlos Singer, Marie Saint‐Hilaire, Tiffany Massood, Karen W. Huskey, Anita L. DeStefano, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Stefano Goldwurm, Gianni Pezzoli, Kenneth B. Baker, Ilia Itin, Irene Litvan, Garth A. Nicholson, Alastair Corbett, Martha Nance, Edward Drasby, Stuart Isaacson, David J. Burn, Patrick F. Chinnery, Peter P. Pramstaller, Jomana T. Al‐Hinti, Anette Torvin Møller, Karen Østergaard, Scott J. Sherman, Richard Roxburgh, Barry Snow, John T. Slevin, Franca Cambi, James F. Gusella, Richard H. Myers   +45 more
openalex   +1 more source

Combating infections under siege: Healthcare challenges amidst the military assault in Gaza

World Medical &Health Policy, Volume 17, Issue 1, Page 188-213, March 2025.
Abstract The ongoing Israeli military assault on Gaza has caused a devastating collapse of healthcare infrastructure, resulting in an unprecedented surge in infectious diseases. The destruction of sanitation systems, restrictions on medical supplies, and displacement of civilians have created an environment conducive to the rapid spread of waterborne ...
Bilal Irfan, Izzeddin Lulu, Adam Hamawy, Abdallah Abu Shammala, Susan Kullab, Mohamed Fawaz, Abd Al‐Karim Sammour, Haseeb Khawaja, Nour Alshaer, Ghassan Abu‐Sittah, Osaid Alser, Mark Perlmutter, Anas Al‐Shembari, Jeremy Hickey, Tariq Nayfeh, Mohammed Tahir, Muhammad Junaid Sultan, Elias Nasser, Muaaz Wajahath, Aneela Yaqoob, Ahmad Hasan, Ali Elaydi, Abdullah Ghali, Mosab Nasser, Khaled J. Saleh   +24 more
wiley   +1 more source

Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. [PDF]

Neurol Ther
Pérez-Pérez J, García-López S, Valle TF, Painous C, Querol-Pascual MR, Ruiz PJG, Diago EB, Cubo Delgado E, Pastor BV, Villaplana MCP, Santana IM, Blázquez Estrada M, Garride MC, Mir P, Álvarez C, Maurino J, de Prado A, López-Sendón JL.   +17 more
europepmc   +1 more source

[Gene Therapy for Huntington Disease]. [PDF]

Fortschr Neurol Psychiatr, 2023
Bräuer S, Falkenburger B.
europepmc   +1 more source

IGF2‐Reprogrammed Macrophages Ameliorate the Inflammatory Response and Protect Against the Neuroinflammatory Process in Parkinson's Disease Models

Aging Cell, EarlyView.
Therapeutic Effects of IGF2‐Reprogrammed Macrophages (MIGF2) in Parkinson's Disease Progression in ASO Mice: This graphical abstract illustrates the therapeutic potential of IGF2‐reprogrammed macrophages (MIGF2) in mitigating Parkinson's disease progression in ASO mice.
Felipe Grunenwald, Tomas J. Huerta, Denisse Sepulveda, Carolina Jerez, Valentina Urbina, Bárbara Carrera, Rodrigo Diaz‐Espinoza, Esteban Nova, Rodrigo Pacheco, Elisa Martín‐Montañez, Sara Gil‐Rodriguez, Nadia Valverde, María Garcia‐Fernandez, Carlos Aguilera, Pedro Chana‐Cuevas, René L. Vidal   +15 more
wiley   +1 more source

Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease: Considering Nonmotor Presentations. [PDF]

Neurol Clin Pract
Considine CM, Eddy CM, Frank SA, Kostyk SK, Oosterloo M, Killoran A, Furr Stimming E, Dose M, Cruickshank T, Bird TD, Vetter L, Arnesen A, Valvano J, Lange HW, Claassen DO.   +14 more
europepmc   +1 more source